Prostaglandin F2 alpha promotes the inhibitory action of endothelin-1 on the bovine luteal function in vitro.
Prostaglandin F2 alpha (PGF2 alpha) is a primary luteolysin in the cow. Although the mechanisms involved in luteolysis are thought to be a complex of its direct action on luteal cells and indirect effect on luteal blood flow, the detailed mechanisms remain to be elucidated. This study focuses on the possible interaction of endothelial cells-derived endothelin-1 (ET-1) with PGF2 alpha in the rapid suppression of progesterone release from the bovine corpus luteum (CL). In in vitro microdialysis system (MDS) of CL, PGF2 alpha acutely stimulated the release of progesterone and oxytocin during infusion and ET-1 release after infusion. Moreover, PGF2 alpha induced slight decrease of progesterone release during the last period of the experiment (8-11 h after PGF2 alpha exposure). Two 1 h-perfusions of ET-1 at 3 h intervals induced only a slight decrease of progesterone release after the second perfusion. This treatment also affected the oxytocin release; the first ET-1 perfusion produced an acute stimulation, whereas the second ET-1 perfusion inhibited the release to below 50%. When the CL pieces were pre-perfused with PGF2 alpha for 2 h, the two consecutive perfusion of ET-1 at 3 h intervals induced drastic decrease in progesterone and oxytocin release only after the second ET-1 perfusion. Thus, a pre-exposure with PGF2 alpha clearly potentiated the inhibiting activity of ET-1 in the progesterone release. These results suggest a physiological impact of PGF2 alpha and ET-1 in the rapid cascade of functional luteolysis in vivo, and a possible interaction between endothelial cells and luteal cells.
Miyamoto
A
A
Department of Animal Genetics and Reproduction, University Farm, Obihiro University of Agriculture and Veterinary Medicine, Japan.
Kobayashi
S
S
Arata
S
S
Ohtani
M
M
Fukui
Y
Y
Schams
D
D
D000818:Animals; D002417:Cattle; D003338:Corpus Luteum / Q000187:drug effects* / Q000378:metabolism; D046508:Culture Techniques; D003864:Depression, Chemical; D015237:Dinoprost / Q000494:pharmacology*; D004357:Drug Synergism; D019332:Endothelin-1 / Q000494:pharmacology*; D005260:Female; D010121:Oxytocin / Q000378:metabolism; D011374:Progesterone / Q000378:metabolism
D019332:Endothelin-1; D011374:Progesterone; D010121:Oxytocin; D015237:Dinoprost